Related references
Note: Only part of the references are listed.Gain-of-Function Mutant p53 R273H Interacts with Replicating DNA and PARP1 in Breast Cancer
Gu Xiao et al.
CANCER RESEARCH (2020)
WEE1 inhibitor, AZD1775, overcomes trastuzumab resistance by targeting cancer stem-like properties in HER2-positive breast cancer
Andrea Sand et al.
CANCER LETTERS (2020)
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
David S. Hong et al.
BRITISH JOURNAL OF CANCER (2020)
Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer
Luisa F. Escobar-Hoyos et al.
CANCER CELL (2020)
Metabolic Adaptations in Cancer Stem Cells
Umesh Prasad Yadav et al.
FRONTIERS IN ONCOLOGY (2020)
Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome
Valeria Capaci et al.
NATURE COMMUNICATIONS (2020)
MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer
Lu Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Cancer Stem Cells and Radioresistance: DNA Repair and Beyond
Alexander Schulz et al.
CANCERS (2019)
P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs
Yuechao Zhao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Genome-Wide Small RNA Sequencing Identifies MicroRNAs Deregulated in Non-Small Cell Lung Carcinoma Harboring Gain-of-Function Mutant p53
Arindam Datta et al.
GENES (2019)
Mutant p53 as a guardian of the cancer cell
Fiamma Mantovani et al.
CELL DEATH AND DIFFERENTIATION (2019)
Poly(ADP-Ribose) Polymerase Inhibition Sensitizes Colorectal Cancer-Initiating Cells to Chemotherapy
Awad Jarrar et al.
STEM CELLS (2019)
p53 balances between tissue hierarchy and anarchy
Gabriela Koifman et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2019)
Mutant p53 in cancer therapy-the barrier or the path
Xiang Zhou et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2019)
Mechanical cues control mutant p53 stability through a mevalonate-RhoA axis
Eleonora Ingallina et al.
NATURE CELL BIOLOGY (2018)
Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others
Kanaga Sabapathy et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma
Alexander Jethwat et al.
BLOOD (2018)
Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells
Huong Thuy Le et al.
CANCER LETTERS (2018)
New therapeutic strategies to treat human cancers expressing mutant p53 proteins
Giovanni Blandino et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers
Hilla Solomon et al.
ONCOGENE (2018)
p53 orchestrates DNA replication restart homeostasis by suppressing mutagenic RAD52 and POL theta pathways
Sunetra Roy et al.
ELIFE (2018)
Targeting cancer stem cells and their niche: perspectives for future therapeutic targets and strategies
Yue Zhao et al.
SEMINARS IN CANCER BIOLOGY (2018)
Targeting mutant p53 for efficient cancer therapy
Vladimir J. N. Bykov et al.
NATURE REVIEWS CANCER (2018)
Targeting mutant p53 in cancer: a long road to precision therapy
Fiamma Mantovani et al.
FEBS JOURNAL (2017)
ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance
Romana-Rea Begicevic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Mitophagy Controls the Activities of Tumor Suppressor p53 to Regulate Hepatic Cancer Stem Cells
Kai Liu et al.
MOLECULAR CELL (2017)
A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer
Felipe de Sousa e Melo et al.
NATURE (2017)
Visualization and targeting of LGR5+ human colon cancer stem cells
Mariko Shimokawa et al.
NATURE (2017)
Cancer stem cells revisited
Eduard Batlle et al.
NATURE MEDICINE (2017)
Mechanobiology of YAP and TAZ in physiology and disease
Tito Panciera et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ
M. Escoll et al.
ONCOGENE (2017)
Mutant p53 perturbs DNA replication checkpoint control through TopBP1 and Treslin
Kang Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
p53 switches off pluripotency on differentiation
Tongxiang Lin et al.
STEM CELL RESEARCH & THERAPY (2017)
Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells
Jia Deng et al.
PLOS ONE (2017)
The proteasome and proteasome inhibitors in multiple myeloma
Sara Gandolfi et al.
CANCER AND METASTASIS REVIEWS (2017)
p53 gain-of-function mutations increase Cdc7-dependent replication initiation
Arindam Datta et al.
EMBO REPORTS (2017)
DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53
S. K. Alam et al.
CELL DEATH AND DIFFERENTIATION (2016)
YAP enhances the pro-proliferative transcriptional activity of mutant p53 proteins
Silvia Di Agostino et al.
EMBO REPORTS (2016)
p53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver Cancer (vol 158, pg 579, 2014)
Darjus F. Tschaharganeh et al.
CELL (2016)
E2 Ubiquitin-conjugating Enzyme, UBE2C Gene, Is Reciprocally Regulated by Wild-type and Gain-of-Function Mutant p53
Swati Bajaj et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Cancer stem cells: understanding tumor hierarchy and heterogeneity
Jeremy N. Rich
MEDICINE (2016)
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition
Marco Cordani et al.
MOLECULAR ONCOLOGY (2016)
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer
Dawid Walerych et al.
NATURE CELL BIOLOGY (2016)
Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cells
Francesca Grespi et al.
CELL DEATH & DISEASE (2016)
Cisplatin induces stemness in ovarian cancer
Andrew Wiechert et al.
ONCOTARGET (2016)
The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression
Jiandong Chen
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy
Wanyin Chen et al.
STEM CELLS INTERNATIONAL (2016)
A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis
Xuetian Yue et al.
CELL DISCOVERY (2016)
Oncogenic intra-p53 Family Member interactions in Human Cancers
Maria Ferraiuolo et al.
FRONTIERS IN ONCOLOGY (2016)
Cellular Homeostasis and Repair in the Mammalian Liver
Ben Z. Stanger
ANNUAL REVIEW OF PHYSIOLOGY, VOL 77 (2015)
Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine
Claudia Fiorini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
Novel role of PELP1 in regulating chemotherapy response in mutant p53-expressing triple negative breast cancer cells
Samaya R. Krishnan et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
TGF-β Promotes Heterogeneity and Drug Resistance in Squamous Cell Carcinoma
Naoki Oshimori et al.
CELL (2015)
The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
Vicki Plaks et al.
CELL STEM CELL (2015)
Antithetical NFATc1-Sox2 and p53-miR200 signaling networks govern pancreatic cancer cell plasticity
Shiv K. Singh et al.
EMBO JOURNAL (2015)
Harnessing the apoptotic programs in cancer stem-like cells
Ying-Hua Wang et al.
EMBO REPORTS (2015)
The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer
Zhongwu Li et al.
MOLECULAR ONCOLOGY (2015)
Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment
E. M. Alexandrova et al.
NATURE (2015)
Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer
Shuo Wei et al.
NATURE MEDICINE (2015)
Proteome-wide analysis of mutant p53 targets in breast cancer identifies new levels of gain-of-function that influence PARP, PCNA, and MCM4
Alla Polotskaia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
p53 Loss Increases the Osteogenic Differentiation of Bone Marrow Stromal Cells
Yunlong He et al.
STEM CELLS (2015)
Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53
E. K. Park et al.
CELL DEATH & DISEASE (2015)
Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities
Madhusudhan Kollareddy et al.
NATURE COMMUNICATIONS (2015)
BAG2 promotes tumorigenesis through enhancing mutant p53 protein levels and function
Xuetian Yue et al.
ELIFE (2015)
The p53 Isoform Δ133p53β Promotes Cancer Stem Cell Potential
Nikola Arsic et al.
STEM CELL REPORTS (2015)
Regulation of Mutant p53 Protein Expression
Reshma Vijayakumaran et al.
FRONTIERS IN ONCOLOGY (2015)
The p53-induced lincRNA-p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters
Xichen Bao et al.
CELL RESEARCH (2015)
Mutant p53 gains new function in promoting inflammatory signals by repression of the secreted interleukin-1 receptor antagonist
V. Ubertini et al.
ONCOGENE (2015)
A mutant p53/let-7i-axis-regulated gene network drives cell migration, invasion and metastasis
M. Subramanian et al.
ONCOGENE (2015)
Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression
Fabio Valenti et al.
ONCOTARGET (2015)
Gain of Function of Mutant TP53 in Glioblastoma: Prognosis and Response to Temozolomide
Xiang Wang et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Interaction of mutant p53 with p73: A Surface Plasmon Resonance and Atomic Force Spectroscopy study
Simona Santini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Patricia A. J. Muller et al.
CANCER CELL (2014)
Gain-of-function of mutant p53: mutant p53 enhances cancer progression by inhibiting KLF17 expression in invasive breast carcinoma cells
Amjad Ali et al.
CANCER LETTERS (2014)
Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling
Susann Weissmueller et al.
CELL (2014)
The onset of p53 loss of heterozygosity is differentially induced in various stem cell types and may involve the loss of either allele
Y. Shetzer et al.
CELL DEATH AND DIFFERENTIATION (2014)
Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast
Alessandra Rustighi et al.
EMBO MOLECULAR MEDICINE (2014)
Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer (vol 5, pg 707, 2013)
Maura Sonego et al.
EMBO MOLECULAR MEDICINE (2014)
p53: The barrier to cancer stem cell formation
Ronit Aloni-Grinstein et al.
FEBS LETTERS (2014)
Different TP53 Mutations are Associated with Specific Chromosomal Rearrangements, Telomere Length Changes, and Remodeling of the Nuclear Architecture of Telomeres
Oumar Samassekou et al.
GENES CHROMOSOMES & CANCER (2014)
Mutant p53 Regulates Dicer through p63-dependent and -independent Mechanisms to Promote an Invasive Phenotype
Patricia A. J. Muller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis
Antti Arjonen et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Long-lived intestinal tuft cells serve as colon cancer-initiating cells
C. Benedikt Westphalen et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Gain-of-Function Mutant p53 Promotes Cell Growth and Cancer Cell Metabolism via Inhibition of AMPK Activation
Ge Zhou et al.
MOLECULAR CELL (2014)
Metabolic control of YAP and TAZ by the mevalonate pathway
Giovanni Sorrentino et al.
NATURE CELL BIOLOGY (2014)
Tackling the cancer stem cells - what challenges do they pose?
Diwakar R. Pattabiraman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Genome-wide profiling reveals stimulus-specific functions of p53 during differentiation and DNA damage of human embryonic stem cells
Kadir C. Akdemir et al.
NUCLEIC ACIDS RESEARCH (2014)
A fine-scale dissection of the DNA double-strand break repair machinery and its implications for breast cancer therapy
Chao Liu et al.
NUCLEIC ACIDS RESEARCH (2014)
Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells
S. Masciarelli et al.
ONCOGENE (2014)
MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells
P. Ceppi et al.
ONCOGENE (2014)
Pla2g16 phospholipase mediates gain-of-function activities of mutant p53
Shunbin Xiong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Maintains the Pluripotency of Human Embryonic Stem Cells by Inactivating p53 Through Sirt1Mediated Deacetylation
Zhen-Ning Zhang et al.
STEM CELLS (2014)
A gain-of-function mutant p53-HSF1 feed forward circuit governs adaptation of cancer cells to proteotoxic stress
D. Li et al.
CELL DEATH & DISEASE (2014)
SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker
Vamsi K. Kolukula et al.
ONCOTARGET (2014)
Mutant p53 Prolongs NF-κB Activation and Promotes Chronic Inflammation and Inflammation-Associated Colorectal Cancer
Tomer Cooks et al.
CANCER CELL (2013)
Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties
Sarah Schwitalla et al.
CELL (2013)
Wild-type p53 suppresses the epithelial-mesenchymal transition and sternness in PC-3 prostate cancer cells by modulating miR-145
Dong Ren et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Id4 dependent acetylation restores mutant-p53 transcriptional activity
Ashley E. Knowell et al.
MOLECULAR CANCER (2013)
Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche
Andrea Flesken-Nikitin et al.
NATURE (2013)
First microRNA mimic enters clinic
Aaron Bouchie
NATURE BIOTECHNOLOGY (2013)
Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion
P. A. J. Muller et al.
ONCOGENE (2013)
Mutant p53 drives invasion in breast tumors through up-regulation of miR-155
P. M. Neilsen et al.
ONCOGENE (2013)
Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis
P. Dong et al.
ONCOGENE (2013)
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
M. Angela Nieto
SCIENCE (2013)
Mutant p53-R273H gains new function in sustained activation of EGFR signaling via suppressing miR-27a expression
W. Wang et al.
CELL DEATH & DISEASE (2013)
The p53-PUMA axis suppresses iPSC generation
Yanxin Li et al.
NATURE COMMUNICATIONS (2013)
Differential regulation of the REGγ-proteasome pathway by p53/TGF-β signalling and mutant p53 in cancer cells
Amjad Ali et al.
NATURE COMMUNICATIONS (2013)
Tumour-associated mutant p53 drives the Warburg effect
Cen Zhang et al.
NATURE COMMUNICATIONS (2013)
Targeting Mutant p53 by a SIRT1 Activator YK-3-237 Inhibits the Proliferation of Triple-Negative Breast Cancer Cells
Yong Weon Yi et al.
ONCOTARGET (2013)
A Novel PTEN/Mutant p53/c-Myc/Bcl-XL Axis Mediates Context-Dependent Oncogenic Effects of PTEN with Implications for Cancer Prognosis and Therapy
Xiaoping Huang et al.
NEOPLASIA (2013)
Metastatic Colonization Requires the Repression of the Epithelial-Mesenchymal Transition Inducer Prrx1
Oscar H. Ocana et al.
CANCER CELL (2012)
Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
William A. Freed-Pastor et al.
CELL (2012)
Dietary downregulation of mutant p53 levels via glucose restriction Mechanisms and implications for tumor therapy
Olga Catalina Rodriguez et al.
CELL CYCLE (2012)
MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function
S. Donzelli et al.
CELL DEATH AND DIFFERENTIATION (2012)
Regulation of Embryonic and Induced Pluripotency by Aurora Kinase-p53 Signaling
Dung-Fang Lee et al.
CELL STEM CELL (2012)
Cancer Stem Cells: Current Status and Evolving Complexities
Jane E. Visvader et al.
CELL STEM CELL (2012)
Therapeutic targeting of the p53 pathway in cancer stem cells
Varun V. Prabhu et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Mutant p53: one name, many proteins
William A. Freed-Pastor et al.
GENES & DEVELOPMENT (2012)
Mammary Epithelial Cell Polarity Is Regulated Differentially by p73 Isoforms via Epithelial-to-mesenchymal Transition
Yanhong Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Broader utilization of origins of DNA replication in cancer cell lines along a 78?kb region of human chromosome 2q34
Manuel S. Valenzuela et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Links between mutant p53 and genomic instability
Walter Hanel et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen et al.
NATURE (2012)
Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer
Paola Tucci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
p53-Facilitated miR-199a-3p Regulates Somatic Cell Reprogramming
Jiaxu Wang et al.
STEM CELLS (2012)
Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
Michael N. Pollak
CANCER DISCOVERY (2012)
p53 Regulates Cell Cycle and MicroRNAs to Promote Differentiation of Human Embryonic Stem Cells
Abhinav K. Jain et al.
PLOS BIOLOGY (2012)
Nanog-induced dedifferentiation of p53-deficient mouse astrocytes into brain cancer stem-like cells
Jai-Hee Moon et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Aurora A mediates cross-talk between N- and C-terminal post-translational modifications of p53
Lorna Jane Warnock et al.
CANCER BIOLOGY & THERAPY (2011)
A Pin1/Mutant p53 Axis Promotes Aggressiveness in Breast Cancer
Javier E. Girardini et al.
CANCER CELL (2011)
Multiple Stress Signals Activate Mutant p53 In Vivo
Young-Ah Suh et al.
CANCER RESEARCH (2011)
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
Piyush B. Gupta et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
p53-dependent regulation of growth, epithelial-mesenchymal transition and stemness in normal pancreatic epithelial cells
Andreia V. Pinho et al.
CELL CYCLE (2011)
Mutant p53 oncogenic functions are sustained by Plk2 kinase through an autoregulatory feedback loop
Fabio Valenti et al.
CELL CYCLE (2011)
Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy
W-J Lu et al.
CELL DEATH AND DIFFERENTIATION (2011)
SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis
D. Li et al.
CELL DEATH AND DIFFERENTIATION (2011)
WEE1 Kinase Targeting Combined with DNA-Damaging Cancer Therapy Catalyzes Mitotic Catastrophe
Philip C. De Witt Hamer et al.
CLINICAL CANCER RESEARCH (2011)
Cancer stem cells and angiogenesis
Yue Zhao et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2011)
Functional Inactivation of Endogenous MDM2 and CHIP by HSP90 Causes Aberrant Stabilization of Mutant p53 in Human Cancer Cells
Dun Li et al.
MOLECULAR CANCER RESEARCH (2011)
p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs
Chun-Ju Chang et al.
NATURE CELL BIOLOGY (2011)
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Can Liu et al.
NATURE MEDICINE (2011)
The cancer stem cell: premises, promises and challenges
Hans Clevers
NATURE MEDICINE (2011)
A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
Repression of Mammary Stem/Progenitor Cells by p53 Is Mediated by Notch and Separable from Apoptotic Activity
Luwei Tao et al.
STEM CELLS (2011)
Intestinal Crypt Homeostasis Results from Neutral Competition between Symmetrically Dividing Lgr5 Stem Cells
Hugo J. Snippert et al.
CELL (2010)
A MicroRNA Targeting Dicer for Metastasis Control
Graziano Martello et al.
CELL (2010)
Hedgehog controls neural stem cells through p53-independent regulation of Nanog
Agnese Po et al.
EMBO JOURNAL (2010)
NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53
Marie Zbinden et al.
EMBO JOURNAL (2010)
p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewal
Zhen Zhao et al.
GENES & DEVELOPMENT (2010)
Δ40p53 controls the switch from pluripotency to differentiation by regulating IGF signaling in ESCs
Erica Ungewitter et al.
GENES & DEVELOPMENT (2010)
Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells
Rachel Sarig et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Selective activation of p53-mediated tumour suppression in high-grade tumours
Melissa R. Junttila et al.
NATURE (2010)
A genomewide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cells
Kyoung-Hwa Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures
Hideaki Mizuno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Intestinal Stem Cell Replacement Follows a Pattern of Neutral Drift
Carlos Lopez-Garcia et al.
SCIENCE (2010)
p53 and stem cells: new developments and new concerns
Tongbiao Zhao et al.
TRENDS IN CELL BIOLOGY (2010)
Mutant p53 Gain-of-Function in Cancer
Moshe Oren et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Clinical Outcomes and Correlates of TP53 Mutations and Cancer
Ana I. Robles et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
Magali Olivier et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Abrogation of the G(2) Checkpoint by Inhibition of Wee-1 Kinase Results in Sensitization of p53-Deficient Tumor Cells to DNA-Damaging Agents
Suzanne Leijen et al.
CURRENT CLINICAL PHARMACOLOGY (2010)
p53 hot-spot mutants increase tumor vascularization via ROS-mediated activation of the HIF1/VEGF-A pathway
N. V. Khromova et al.
CANCER LETTERS (2009)
The Tumor Suppressor p53 Regulates Polarity of Self-Renewing Divisions in Mammary Stem Cells
Angelo Cicalese et al.
CELL (2009)
Mutant p53 Drives Invasion by Promoting Integrin Recycling
Patricia A. J. Muller et al.
CELL (2009)
A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
Maddalena Adorno et al.
CELL (2009)
Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
Yohei Shimono et al.
CELL (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers
Barbara Stecca et al.
EMBO JOURNAL (2009)
p53 regulates the proliferation, differentiation and spontaneous transformation of mesenchymal stem cells
Alejandro Armesilla-Diaz et al.
EXPERIMENTAL CELL RESEARCH (2009)
STEM CELLS The promises and perils of p53
Valery Krizhanovsky et al.
NATURE (2009)
Linking the p53 tumour suppressor pathway to somatic cell reprogramming
Teruhisa Kawamura et al.
NATURE (2009)
A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity
Rosa M. Marion et al.
NATURE (2009)
Suppression of induced pluripotent stem cell generation by the p53-p21 pathway
Hyenjong Hong et al.
NATURE (2009)
The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis
Giulia Fontemaggi et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
p53 REGULATES THE SELF-RENEWAL AND DIFFERENTIATION OF NEURAL PRECURSORS
A. Armesilla-Diaz et al.
NEUROSCIENCE (2009)
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
Qing Ji et al.
PLOS ONE (2009)
Loss of p53 Induces Tumorigenesis in p21-Deficient Mesenchymal Stem Cells
Rene Rodriguez et al.
NEOPLASIA (2009)
When mutants gain new powers: news from the mutant p53 field
Ran Brosh et al.
NATURE REVIEWS CANCER (2009)
Non-genotoxic anti-neoplastic effects of ellipticine derivative NSC176327 in p53-deficient human colon carcinoma cells involve stimulation of p73
Chao Lu et al.
CANCER BIOLOGY & THERAPY (2008)
Peptide aptamers targeting mutant p53 induce apoptosis in tumor cells
Elisa Guida et al.
CANCER RESEARCH (2008)
Growth-inhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expression
Samuel Godar et al.
CELL (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Mre11 nuclease activity has essential roles in DNA repair and genomic stability distinct from ATM activation
Jeffrey Buis et al.
CELL (2008)
SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization
Myung-Kwan Han et al.
CELL STEM CELL (2008)
Two Supporting Factors Greatly Improve the Efficiency of Human iPSC Generation
Yang Zhao et al.
CELL STEM CELL (2008)
Bmi1 regulates stem cells and proliferation and differentiation of committed cells in mammary epithelium
Alexandra M. Pietersen et al.
CURRENT BIOLOGY (2008)
A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
Ulrike Burk et al.
EMBO REPORTS (2008)
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
Sun-Mi Park et al.
GENES & DEVELOPMENT (2008)
The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss
Tamara Terzian et al.
GENES & DEVELOPMENT (2008)
A gene signature-based approach identifies mTOR as a regulator of p73
Jennifer M. Rosenbluth et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
The cancer stem cell hypothesis: in search of definitions, markers, and relevance
Michail Shipitsin et al.
LABORATORY INVESTIGATION (2008)
NUMB controls p53 tumour suppressor activity
Ivan N. Colaluca et al.
NATURE (2008)
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation
Hongwu Zheng et al.
NATURE (2008)
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors
Ittai Ben-Porath et al.
NATURE GENETICS (2008)
Dissecting the role of p53 phosphorylation in homologous recombination provides new clues for gain-of-function mutants
Anja Restle et al.
NUCLEIC ACIDS RESEARCH (2008)
Activation of p53 by nutlin leads to rapid differentiation of human embryonic stem cells
T. Maimets et al.
ONCOGENE (2008)
Chaperone-dependent stabilization and degradation of p53 mutants
P. Muller et al.
ONCOGENE (2008)
Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
Anne-Pierre Morel et al.
PLOS ONE (2008)
p53 Plays a Role in Mesenchymal Differentiation Programs, in a Cell Fate Dependent Manner
Alina Molchadsky et al.
PLOS ONE (2008)
Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway
J. E. Kravchenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
p53 is required for etoposide-induced apoptosis of human embryonic stem cells
C. Grandela et al.
STEM CELL RESEARCH (2008)
ΔNp73α regulates MDR1 expression by inhibiting p53 function
A. Vilgelm et al.
ONCOGENE (2008)
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Jane E. Visvader et al.
NATURE REVIEWS CANCER (2008)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
p53 regulates maternal reproduction through LIF
Wenwei Hu et al.
NATURE (2007)
Orchestration of chromatin-based processes:: mind the TRRAP
R. Murr et al.
ONCOGENE (2007)
Strategies and new developments in the generation of patient-specific pluripotent stem cells
Shinya Yamanaka
CELL STEM CELL (2007)
Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Hector Peinado et al.
NATURE REVIEWS CANCER (2007)
Mevalonate pathway: A review of clinical and therapeutical implications
Irina Buhaescu et al.
CLINICAL BIOCHEMISTRY (2007)
P53 gain-of-function cancer mutants induce genetic instability by inactivating ATM
Hoseok Song et al.
NATURE CELL BIOLOGY (2007)
Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?
Y. Li et al.
ONCOGENE (2007)
Mutant p53: an oncogenic transcription factor
S. Strano et al.
ONCOGENE (2007)
Mutant p53 enhances nuclear factor κB activation by tumor necrosis factor α in cancer cells
Lilach Weisz et al.
CANCER RESEARCH (2007)
Regulation of apoptosis and differentiation by p53 in human embryonic stem cells
Han Qin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The oncogenic roles of p53 mutants in mouse models
Guillermina Lozano
CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)
One, two, three -: p53, p63, p73 and chemosensitivity
Martina Mueller et al.
DRUG RESISTANCE UPDATES (2006)
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Kazutoshi Takahashi et al.
CELL (2006)
Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor
Shideng Bao et al.
CANCER RESEARCH (2006)
Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenografts
Wenge Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Tumor-derived p53 mutants induce NF-κB2 gene expression
MJ Scian et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
LD Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Opinion - Migrating cancer stem cells - an integrated concept of malignant tumour progression
T Brabletz et al.
NATURE REVIEWS CANCER (2005)
Blockage of NF-κB induces serine 15 phosphorylation of mutant p53 by JNK kinase in prostate cancer cells
LF Zerbini et al.
CELL CYCLE (2005)
P53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression
TX Lin et al.
NATURE CELL BIOLOGY (2005)
Metaplastic breast carcinoma with squamous differentiation: Molecular and clinical analysis of six cases
R Kochhar et al.
BREAST JOURNAL (2005)
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
GA Lang et al.
CELL (2004)
Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes
MJ Scian et al.
ONCOGENE (2004)
Post-translational modification of p53 in tumorigenesis
AM Bode et al.
NATURE REVIEWS CANCER (2004)
Mono-versus polyubiquitination: Differential control of p53 fate by Mdm2
MY Li et al.
SCIENCE (2003)
Mutant p53 is constitutively phosphorylated at Serine 15 in UV-induced mouse skin tumors: involvement of ERK1/2 MAP kinase
VO Melnikova et al.
ONCOGENE (2003)
ABC transporters as phenotypic markers and functional regulators of stem cells
KD Bunting
STEM CELLS (2002)
Inhibition of MDM2 by hsp90 contributes to mutant p53 stabilization
YH Peng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Distinct pattern of p53 phosphorylation in human tumors
T Minamoto et al.
ONCOGENE (2001)
A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain
C Gaiddon et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Share Paper
